XM does not provide services to residents of the United States of America.
U
U

UniversalHealth

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Elevance Health, Wesco International, WW Grainger

U.S. RESEARCH ROUNDUP-Elevance Health, Wesco International, WW Grainger May 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.listed companies including Elevance Health, Wesco International and WW Grainger, on Thursday. HIGHLIGHTS * Cigna Group CI.N : JP Morgan raises target price to $435 from $432 * Elevance Health Inc ELV.N : JP Morgan raises target price to $631 from $628 * Uipath Inc PATH.N : TD Cowen cuts to hold from buy * Wesco Internati
A
C
C
E
F
S
A
E
H
W
A
L
U

U.S. Domino's Pizza, HCA Healthcare, WW Grainger

U.S. RESEARCH ROUNDUP-Domino's Pizza, HCA Healthcare, WW Grainger April 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Domino's Pizza, HCA Healthcare and WW Grainger, on Tuesday. HIGHLIGHTS * Domino's Pizza Inc DPZ.N : BTIG raises target price to $580 from $515 * HCA Healthcare Inc HCA.N : TD Cowen cuts target price to $360 from $371 * Molina Healthcare Inc MOH.N : TD Cowen cuts target price to $412 from $453 * W
A
C
C
X
O
A
H
W
E
U

HCA Healthcare slips after maintaining annual forecast

BUZZ-HCA Healthcare slips after maintaining annual forecast ** Shares of hospital operator HCA Healthcare HCA.N fall 3.7% to $302.04 ** HCA beat Q1 profit and revenue estimates, but left its annual forecast unchanged ** At least two analysts say unchanged outlook may disappoint investors after the firm reported better-than-expected results ** "The
H
U

HCA's unchanged annual forecast clouds better-than-expected quarter

UPDATE 4-HCA's unchanged annual forecast clouds better-than-expected quarter Recasts paragraph 1, adds company comments from conference call in paragraph 3 By Sriparna Roy and Sneha S K April 26 (Reuters) - HCA Healthcare HCA.N on Friday beat Wall Street estimates for quarterly profit and revenue but left its annual forecast unchanged, sending shares of the largest for-profit US hospital operator down nearly 5%.
H
U

HCA Healthcare beats first quarter profit helped by higher patient admissions

HCA Healthcare beats first quarter profit helped by higher patient admissions April 26 (Reuters) - HCA Healthcare HCA.N on Friday beat Wall Street estimates for quarterly profit, helped by higher patient admissions due to demand for healthcare services. The largest for-profit hospital operator in the United States reported an adjusted profit of $5.36 per share for the quarter.
H
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.